Why is Clinitech Lab falling/rising?

As of 30-Jul, Clinitech Laboratory Ltd is currently priced at 31.00, with no change in price (0.00%). The stock has shown a performance inline with its sector today, but it has been experiencing erratic trading, having not traded on 2 out of the last 20 days. Additionally, Clinitech Lab is trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a downward trend. The delivery volume has significantly decreased, with a drop of 85.92% against the 5-day average, suggesting falling investor participation. The stock's year-to-date return is notably poor at -60.69%, contrasting sharply with the Sensex's positive return of +4.28%.
In the broader market context, Clinitech Lab's short-term return over the past week is +1.14%, while the benchmark Sensex has declined by -1.50%. This indicates that Clinitech Lab has outperformed the benchmark in the short term, despite its overall negative performance year-to-date. The stock's liquidity is deemed sufficient for trading, but the significant drop in delivery volume and the overall negative sentiment surrounding the stock may contribute to its recent struggles. There are no specific positive or negative factors available to further clarify the stock's recent movements.